Looking beyond the leukemic cell for answers
Christopher Pepper et al.
Prospects of treating CLL and their complications
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
Do patients with CLL require CAR T-cell therapy?
Next steps for advancing the molecular stratification of CLL